NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Look, the big deal tomorrow are the ASCO title releases for companies. Despite my opinion to the contrary, if NWBO has an abstract for DCVax-L therein, then it would make Dr. Sharpless' talk tomorrow very important, because it likely is timed to fall just after the title release. Then, just one or two references to the potential of cancer vaccines could be huge.

However, that's not what is likely to happen. What is likely is that there will be no title release for NWBO tomorrow. They have instead likely booked a room at Industry Expert Theater. We may or may not find out about this booking around April 25th. Even if they don't list NWBO by April 25th, they might still be listed by the beginning of ASCO. If NWBO has no new news, we will likely hear about DCVax-Direct at industry expert theater. Where they might once again prematurely hype impending follow up trials.

David Innes will start to be referred to as miniLes.

If all we hear about is DCVax-Direct, with no indication of topline, the price will sink back down to .17 cents after ASCO. If the price sinks back down to .17 cents, either more dilution will occur, or NWBO will sell off their last discretionary piece of property. If they sell off their discretionary piece of property, they will use the "genius" eyeroll move to further time delay to SNO. If they buy more time to SNO, they will....blah, blah, blah.

Or, NWBO could act like adults and give us their expected month (like Amarin did) for topline, and we could all relax for a while.